These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 20943879)
1. Antibody responses in mice stimulated by various doses of the potato-derived major surface antigen of hepatitis B virus. Youm JW; Won YS; Jeon JH; Moon KB; Kim HC; Shin KS; Joung H; Kim HS Clin Vaccine Immunol; 2010 Dec; 17(12):2029-32. PubMed ID: 20943879 [TBL] [Abstract][Full Text] [Related]
2. Oral delivery of wafers made from HBsAg-expressing maize germ induces long-term immunological systemic and mucosal responses. Hayden CA; Fischer ME; Andrews BL; Chilton HC; Turner DD; Walker JH; Tizard IR; Howard JA Vaccine; 2015 Jun; 33(25):2881-6. PubMed ID: 25944300 [TBL] [Abstract][Full Text] [Related]
3. Oral vaccination of mice with Tremella fuciformis yeast-like conidium cells expressing HBsAg. Shin DI; Song KS; Park HS Biotechnol Lett; 2015 Mar; 37(3):539-44. PubMed ID: 25374008 [TBL] [Abstract][Full Text] [Related]
4. Oral immunogenicity of potato-derived HBsAg middle protein in BALB/c mice. Youm JW; Won YS; Jeon JH; Ryu CJ; Choi YK; Kim HC; Kim BD; Joung H; Kim HS Vaccine; 2007 Jan; 25(3):577-84. PubMed ID: 16945456 [TBL] [Abstract][Full Text] [Related]
5. Oral administration of low doses of plant-based HBsAg induced antigen-specific IgAs and IgGs in mice, without increasing levels of regulatory T cells. Kostrzak A; Cervantes Gonzalez M; Guetard D; Nagaraju DB; Wain-Hobson S; Tepfer D; Pniewski T; Sala M Vaccine; 2009 Jul; 27(35):4798-807. PubMed ID: 19539581 [TBL] [Abstract][Full Text] [Related]
6. Lentivector expressing HBsAg and immunoglobulin Fc fusion antigen induces potent immune responses and results in seroconversion in HBsAg transgenic mice. Hong Y; Peng Y; Mi M; Xiao H; Munn DH; Wang GQ; He Y Vaccine; 2011 May; 29(22):3909-16. PubMed ID: 21421003 [TBL] [Abstract][Full Text] [Related]
7. Supercritical fluid extraction provides an enhancement to the immune response for orally-delivered hepatitis B surface antigen. Hayden CA; Smith EM; Turner DD; Keener TK; Wong JC; Walker JH; Tizard IR; Jimenez-Flores R; Howard JA Vaccine; 2014 Mar; 32(11):1240-6. PubMed ID: 24486361 [TBL] [Abstract][Full Text] [Related]
8. Expression of hepatitis B virus surface antigen determinants in Lactococcus lactis for oral vaccination. Zhang Q; Zhong J; Huan L Microbiol Res; 2011 Feb; 166(2):111-20. PubMed ID: 20227266 [TBL] [Abstract][Full Text] [Related]
10. [Suppression of the antigen-specific T cell immune response by co-immunization with the HBV DNA vaccine and recombinant HBsAg]. Du X; Wang J; Kang Y; Xiao W; Zhao G; Wang B Wei Sheng Wu Xue Bao; 2009 Jul; 49(7):938-42. PubMed ID: 19873759 [TBL] [Abstract][Full Text] [Related]
11. Oral administration of synthetic selenium nanoparticles induced robust Th1 cytokine pattern after HBs antigen vaccination in mouse model. Mahdavi M; Mavandadnejad F; Yazdi MH; Faghfuri E; Hashemi H; Homayouni-Oreh S; Farhoudi R; Shahverdi AR J Infect Public Health; 2017; 10(1):102-109. PubMed ID: 27026241 [TBL] [Abstract][Full Text] [Related]
12. Study of the immunogenicity of hepatitis B surface antigen synthesized in transgenic potato plants with increased biosafety. Rukavtsova EB; Rudenko NV; Puchko EN; Zakharchenko NS; Buryanov YI J Biotechnol; 2015 Jun; 203():84-8. PubMed ID: 25840367 [TBL] [Abstract][Full Text] [Related]
13. M-cell targeted delivery of recombinant hepatitis B surface antigen using cholera toxin B subunit conjugated bilosomes. Shukla A; Katare OP; Singh B; Vyas SP Int J Pharm; 2010 Jan; 385(1-2):47-52. PubMed ID: 19835938 [TBL] [Abstract][Full Text] [Related]
14. Cationic transfersomes based topical genetic vaccine against hepatitis B. Mahor S; Rawat A; Dubey PK; Gupta PN; Khatri K; Goyal AK; Vyas SP Int J Pharm; 2007 Aug; 340(1-2):13-9. PubMed ID: 17446015 [TBL] [Abstract][Full Text] [Related]
15. Immunogenicity in humans of an edible vaccine for hepatitis B. Thanavala Y; Mahoney M; Pal S; Scott A; Richter L; Natarajan N; Goodwin P; Arntzen CJ; Mason HS Proc Natl Acad Sci U S A; 2005 Mar; 102(9):3378-82. PubMed ID: 15728371 [TBL] [Abstract][Full Text] [Related]
16. Longitudinal determination of hepatitis B surface antigen-specific B lymphocyte frequency in healthy high responder adults after booster vaccination. Sam MR; Shokrgozar MA; Shokri F Intervirology; 2008; 51(2):87-95. PubMed ID: 18477849 [TBL] [Abstract][Full Text] [Related]
17. A vectored measles virus induces hepatitis B surface antigen antibodies while protecting macaques against measles virus challenge. del Valle JR; Devaux P; Hodge G; Wegner NJ; McChesney MB; Cattaneo R J Virol; 2007 Oct; 81(19):10597-605. PubMed ID: 17634218 [TBL] [Abstract][Full Text] [Related]
18. Hepatitis B virus surface antigen as delivery vector can enhance Chlamydia trachomatis MOMP multi-epitope immune response in mice. Zhu S; Feng Y; Rao P; Xue X; Chen S; Li W; Zhu G; Zhang L Appl Microbiol Biotechnol; 2014 May; 98(9):4107-17. PubMed ID: 24458565 [TBL] [Abstract][Full Text] [Related]
19. HIV-1 derived peptides fused to HBsAg affect its immunogenicity. Gonzalez MC; Kostrzak A; Guetard D; Pniewski T; Sala M Virus Res; 2009 Dec; 146(1-2):107-14. PubMed ID: 19766153 [TBL] [Abstract][Full Text] [Related]
20. Oral immunization of animals with transgenic cherry tomatillo expressing HBsAg. Gao Y; Ma Y; Li M; Cheng T; Li SW; Zhang J; Xia NS World J Gastroenterol; 2003 May; 9(5):996-1002. PubMed ID: 12717845 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]